Intravenous transplantation of olfactory bulb ensheathing cells for a spinal cord hemisection injury rat model

Cellular transplantation strategies utilizing intraspinal or intrathecal olfactory ensheathing cells (OECs) have been reported as beneficial for spinal cord injury (SCI). However, there are many disadvantages of these methods, including additional trauma to the spinal cord parenchyma and technical c...

Full description

Bibliographic Details
Main Authors: Lijian Zhang, Xiaoqing Zhuang, Yao Chen, Hechun Xia
Format: Article
Language:English
Published: SAGE Publishing 2019-12-01
Series:Cell Transplantation
Online Access:https://doi.org/10.1177/0963689719883842
id doaj-9ba037b418f840918ac2a8d17a918985
record_format Article
spelling doaj-9ba037b418f840918ac2a8d17a9189852020-11-25T03:35:23ZengSAGE PublishingCell Transplantation0963-68971555-38922019-12-012810.1177/0963689719883842Intravenous transplantation of olfactory bulb ensheathing cells for a spinal cord hemisection injury rat modelLijian Zhang0Xiaoqing Zhuang1Yao Chen2Hechun Xia3 Both the authors are co-authors and contributed equally to this article Both the authors are co-authors and contributed equally to this article Ningxia Human Stem Cell Research Institute, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China Ningxia Human Stem Cell Research Institute, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, ChinaCellular transplantation strategies utilizing intraspinal or intrathecal olfactory ensheathing cells (OECs) have been reported as beneficial for spinal cord injury (SCI). However, there are many disadvantages of these methods, including additional trauma to the spinal cord parenchyma and technical challenges. Therefore, we investigated the feasibility and potential benefits of intravenous transplantation of OECs in a rat hemisection SCI model. OECs derived from olfactory bulb tissue were labeled with quantum dots (QDs), and their biodistribution after intravenous transplantation was tracked using a fluorescence imaging system. Accumulation of the transplanted OECs was observed in the injured spinal cord within 10 min, peaked at seven days after cell transplantation, and decreased gradually thereafter. This time window corresponded to the blood–spinal cord barrier (BSCB) opening time, which was quantitated with the Evans blue leakage assay. Using immunohistochemistry, we examined neuronal growth (GAP-43), remyelination (MBP), and microglia (Iba-1) reactions at the lesion site. Motor function recovery was also measured using a classic open field test (Basso, Beattie and Bresnahan score). Compared with the group injected only with QDs, the rats that received OEC transplantation exhibited a prominent reduction in inflammatory responses, increased neurogenesis and remyelination, and significant improvement in motor function. We suggest that intravenous injection could also be an effective method for delivering OECs and improving functional outcomes after SCI. Moreover, the time course of BSCB disruption provides a clinically relevant therapeutic window for cell-based intervention.https://doi.org/10.1177/0963689719883842
collection DOAJ
language English
format Article
sources DOAJ
author Lijian Zhang
Xiaoqing Zhuang
Yao Chen
Hechun Xia
spellingShingle Lijian Zhang
Xiaoqing Zhuang
Yao Chen
Hechun Xia
Intravenous transplantation of olfactory bulb ensheathing cells for a spinal cord hemisection injury rat model
Cell Transplantation
author_facet Lijian Zhang
Xiaoqing Zhuang
Yao Chen
Hechun Xia
author_sort Lijian Zhang
title Intravenous transplantation of olfactory bulb ensheathing cells for a spinal cord hemisection injury rat model
title_short Intravenous transplantation of olfactory bulb ensheathing cells for a spinal cord hemisection injury rat model
title_full Intravenous transplantation of olfactory bulb ensheathing cells for a spinal cord hemisection injury rat model
title_fullStr Intravenous transplantation of olfactory bulb ensheathing cells for a spinal cord hemisection injury rat model
title_full_unstemmed Intravenous transplantation of olfactory bulb ensheathing cells for a spinal cord hemisection injury rat model
title_sort intravenous transplantation of olfactory bulb ensheathing cells for a spinal cord hemisection injury rat model
publisher SAGE Publishing
series Cell Transplantation
issn 0963-6897
1555-3892
publishDate 2019-12-01
description Cellular transplantation strategies utilizing intraspinal or intrathecal olfactory ensheathing cells (OECs) have been reported as beneficial for spinal cord injury (SCI). However, there are many disadvantages of these methods, including additional trauma to the spinal cord parenchyma and technical challenges. Therefore, we investigated the feasibility and potential benefits of intravenous transplantation of OECs in a rat hemisection SCI model. OECs derived from olfactory bulb tissue were labeled with quantum dots (QDs), and their biodistribution after intravenous transplantation was tracked using a fluorescence imaging system. Accumulation of the transplanted OECs was observed in the injured spinal cord within 10 min, peaked at seven days after cell transplantation, and decreased gradually thereafter. This time window corresponded to the blood–spinal cord barrier (BSCB) opening time, which was quantitated with the Evans blue leakage assay. Using immunohistochemistry, we examined neuronal growth (GAP-43), remyelination (MBP), and microglia (Iba-1) reactions at the lesion site. Motor function recovery was also measured using a classic open field test (Basso, Beattie and Bresnahan score). Compared with the group injected only with QDs, the rats that received OEC transplantation exhibited a prominent reduction in inflammatory responses, increased neurogenesis and remyelination, and significant improvement in motor function. We suggest that intravenous injection could also be an effective method for delivering OECs and improving functional outcomes after SCI. Moreover, the time course of BSCB disruption provides a clinically relevant therapeutic window for cell-based intervention.
url https://doi.org/10.1177/0963689719883842
work_keys_str_mv AT lijianzhang intravenoustransplantationofolfactorybulbensheathingcellsforaspinalcordhemisectioninjuryratmodel
AT xiaoqingzhuang intravenoustransplantationofolfactorybulbensheathingcellsforaspinalcordhemisectioninjuryratmodel
AT yaochen intravenoustransplantationofolfactorybulbensheathingcellsforaspinalcordhemisectioninjuryratmodel
AT hechunxia intravenoustransplantationofolfactorybulbensheathingcellsforaspinalcordhemisectioninjuryratmodel
_version_ 1724554709301198848